Moncef Slaoui
Moroccan-American-Belgian doctor and researcher
Moncef Mohamed Slaoui (English:; French: [mɔ̃sɛf slawi]; Moroccan Arabic: منصف السلاوي, IPA: [ˈmonsˤəf ˈsːlæwi]; born July 22, 1959) is a Moroccan-born researcher who served as the head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021.2
From Wikipedia’s article on Moncef Slaoui (this version), CC BY-SA 4.0.
Born Jul 22, 1959.1
About
Slaoui is the former head of the vaccines department at GlaxoSmithKline (GSK). He worked at the company for thirty years, retiring in 2017. On May 15, 2020, President Donald Trump announced that Slaoui would manage the U.S. government's development of a vaccine used to treat coronavirus disease in OPWASP; Slaoui resigned on January 12, 2021 after successfully having helped introduce a number of vaccines to the US and global markets.
In March 2021, Slaoui was fired from the board of GSK subsidiary Galvani Bioelectronics over what GSK called “substantiated” sexual harassment allegations stemming from his time at the parent company. Slaoui issued an apology statement and stepped down from positions at other companies at the same time.
From Wikipedia’s article on Moncef Slaoui, shared under CC BY-SA 4.0.2
Companies
- Lonza GroupBoard member Apr 2020 to May 17, 20203
- ModernaBoard member 2017 to 20204
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataMoncef Slaoui on Wikidata
- 2WikipediaMoncef Slaoui on Wikipedia
- 3WikidataLonza Group, Board member
- 4WikidataModerna, Board member